J
James S. Tweddell
Researcher at Cincinnati Children's Hospital Medical Center
Publications - 319
Citations - 13445
James S. Tweddell is an academic researcher from Cincinnati Children's Hospital Medical Center. The author has contributed to research in topics: Hypoplastic left heart syndrome & Norwood procedure. The author has an hindex of 61, co-authored 300 publications receiving 11600 citations. Previous affiliations of James S. Tweddell include New York University & Washington University in St. Louis.
Papers
More filters
Journal ArticleDOI
Improved survival of patients undergoing palliation of hypoplastic left heart syndrome: Lessons learned from 115 consecutive patients
James S. Tweddell,George M. Hoffman,Kathleen A. Mussatto,Raymond T. Fedderly,Stuart Berger,Robert D.B. Jaquiss,Nancy S. Ghanayem,Stephanie J. Frisbee,S. Bert Litwin +8 more
TL;DR: Improved survival following S1P can be achieved with strategies that allow for early identification of decreased systemic output and the use of afterload reduction to stabilize systemic vascular resistance and therefore the pulmonary to systemic flow ratio.
Journal ArticleDOI
Hypoplastic Left Heart Syndrome : Current Considerations and Expectations
Jeffrey A. Feinstein,D. Woodrow Benson,Anne M. Dubin,Meryl S. Cohen,Dawn M. Maxey,William T. Mahle,Elfriede Pahl,Juan Villafane,Ami B. Bhatt,Lynn F. Peng,Beth Ann Johnson,Alison L. Marsden,Curt J. Daniels,Nancy Rudd,Christopher A. Caldarone,Kathleen A. Mussatto,David L.S. Morales,D. Dunbar Ivy,J. William Gaynor,James S. Tweddell,Barbara J. Deal,Anke K. Furck,Geoffrey L. Rosenthal,Richard G. Ohye,Nancy S. Ghanayem,John P. Cheatham,Wayne Tworetzky,Gerard R. Martin +27 more
TL;DR: The current state of the art in the understanding and treatment of HLHS during the stages of care is presented, including perioperative care, interstage monitoring, and management strategies, and issues surrounding the genetics, developmental outcomes, and quality of life are addressed.
Journal ArticleDOI
Prospective trial of a pediatric ventricular assist device.
Charles D. Fraser,Robert D.B. Jaquiss,David N. Rosenthal,Tilman Humpl,Charles E. Canter,Eugene H. Blackstone,David C. Naftel,Rebecca Ichord,Lisa Bomgaars,James S. Tweddell,M. Patricia Massicotte,Mark W. Turrentine,Gordon A. Cohen,Eric J. Devaney,F. Bennett Pearce,Kathleen E. Carberry,Robert Kroslowitz,Christopher S. Almond +17 more
TL;DR: The trial showed that survival rates were significantly higher with the ventricular assist device than with ECMO, and serious adverse events, including infection, stroke, and bleeding, occurred in a majority of study participants.
Journal ArticleDOI
Home surveillance program prevents interstage mortality after the Norwood procedure.
Nancy S. Ghanayem,George M. Hoffman,Kathleen A. Mussatto,Joseph R. Cava,Peter C. Frommelt,Nancy Rudd,Michelle Steltzer,Sarah M. Bevandic,Stephanie J. Frisbee,Robert D.B. Jaquiss,S. B. Litwin,James S. Tweddell +11 more
TL;DR: Daily home surveillance of arterial oxygen saturation according to pulse oximetry and weight selected patients at increased risk of interstage death, permitting timely intervention, primarily with early stage 2 palliation, and was associated with improved interstage survival.
Journal ArticleDOI
Prevention and Treatment of Thrombosis in Pediatric and Congenital Heart Disease A Scientific Statement From the American Heart Association
Therese M. Giglia,M. Patricia Massicotte,James S. Tweddell,Robyn J. Barst,Mary E. Bauman,Christopher C. Erickson,Timothy F. Feltes,Elyse Foster,Kathleen Hinoki,Rebecca Ichord,Jacqueline Kreutzer,Brian W. McCrindle,Jane W. Newburger,Sarah Tabbutt,Jane L. Todd,Catherine L. Webb +15 more
TL;DR: Thrombosis has long been recognized as a potentially life-threatening complication in children with congenital heart disease (CHD), children with acquired heart disease, and in adults with CHD.